Hospitals facing Obamacare penalties for high readmission rates should heed the results of a new study, says EarlySense
One of the tenets of the Affordable Care Act (ACA), aka Obamacare, is that hospitals must reduce costs, by reducing their 30-day readmission rate — the theory being that a hospital ought to be able to do a good-enough job on patients deemed well enough to be released to keep them out of the hospital for at least a month.
As a result, hospitals are scrambling to find ways to reduce their exposure to the problem. Otherwise, thanks to the Hospital Readmissions Reduction Program component of the ACA, they could find their Medicare payments cut by up to 3%. While it doesn’t sound like a lot overall, hospital administrators, armed with spreadsheets and horror stories, would disagree, claiming they need every penny, and then some.
A new study by Israeli medical technology start-up EarlySense could help allay the concerns of administrators — as well as patients, most of whom presumably would want to avoid going back to the hospital as well. In the first-ever test of the EarlySense system that followed heart-failure patients after hospital discharge, the start-up, working with two top US health institutes, discovered that monitoring the respiratory activity of the patients was “the most important risk-adjusted associate of readmission for heart failure,” according to Dalia Argaman, VP of clinical and regulatory affairs at EarlySense.
With “wearables” all the rage now in health monitoring, EarlySense has done things a bit differently: The company has developed the first “sleepable” in a device which, when placed under a mattress, keeps track of how a person sleeps, including whether they toss or turn, the different stages of sleep (REM, etc.), their breathing, and other important sleep data.